Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H15BrN6O |
Molecular Weight | 435.277 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(=CC(C)=C1OC2=NC(NC3=CC=C(C=C3)C#N)=NC(N)=C2Br)C#N
InChI
InChIKey=PYGWGZALEOIKDF-UHFFFAOYSA-N
InChI=1S/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24,25,26,27)
Molecular Formula | C20H15BrN6O |
Molecular Weight | 435.277 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:55:55 UTC 2023
by
admin
on
Fri Dec 15 15:55:55 UTC 2023
|
Record UNII |
0C50HW4FO1
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
INTELENCE (AUTHORIZED: HIV INFECTIONS)
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
||
|
NCI_THESAURUS |
C97453
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
||
|
WHO-VATC |
QJ05AG04
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
||
|
NDF-RT |
N0000175463
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
||
|
NDF-RT |
N0000009948
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
||
|
LIVERTOX |
NBK548290
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
||
|
WHO-ATC |
J05AG04
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
||
|
NDF-RT |
N0000175460
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
193962
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
DTXSID30181412
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
m5205
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | Merck Index | ||
|
ETRAVIRINE
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
269055-15-4
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
8303
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
CHEMBL308954
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
C451734
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
RR-30
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
0C50HW4FO1
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
C73195
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
100000089817
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
SUB25650
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
0C50HW4FO1
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
1266824
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
Etravirine
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
475969
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | RxNorm | ||
|
63589
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
1115
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY | |||
|
DB06414
Created by
admin on Fri Dec 15 15:55:55 UTC 2023 , Edited by admin on Fri Dec 15 15:55:55 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> INDUCER | |||
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> INHIBITOR |
ANTAGONIST
IC50
|
||
|
EXCRETED UNCHANGED |
AMOUNT EXCRETED
FECAL
|
||
|
TRANSPORTER -> INHIBITOR |
WEAK
IC50
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
EXCRETED UNCHANGED |
No unchanged drug was recovered in the urine.
URINE
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
PARENT -> METABOLITE | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
ORAL ADMINISTRATION |
|
||